REGENERON PHARMACEUTICALS (REGN)

US75886F1075 - Common Stock

989.28  +8.08 (+0.82%)

After market: 989.28 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
3.95B4.34B8.08B3.51B2.12B
Depreciation Amortization
421.00M341.40M286.20M235.90M210.30M
Income Taxes - Deferred
-837.80M-746.40M-147.10M75.60M-130.60M
Change In Working Capital
-94.10M-243.30M-1.92B-1.50B-200.50M
Interest Paid
73.10M53.70M55.80M23.20M25.00M
Taxes Paid
870.30M1.50B1.22B188.10M342.30M
Other non cash items
1.15B1.32B783.40M297.00M435.00M
OPERATING CASH FLOW
4.59B5.01B7.08B2.62B2.43B
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-926.40M-1.62B-551.90M-614.60M-429.60M
Other Investing Activity
-2.26B-2.17B-4.83B544.00M-1.60B
INVESTING CASH FLOW
-3.19B-3.78B-5.38B-70.60M-2.03B
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/A0.000.001.98BN/A
Stock Issued/Repurchased
-1.09B-563.30M26.90M-3.27B-64.10M
Other Financing Activity
-700.60M-445.70M-1.03B-680.80M-188.00M
FINANCING CASH FLOW
-1.79B-1.01B-1.01B-1.97B-252.10M
 
Exchange Rate Effect
-400.00KN/AN/AN/AN/A
CHANGE IN CASH
-381.60M221.30M690.80M577.00M150.10M
 
FREE CASH FLOW
Operating Cash Flow
4.59B5.01B7.08B2.62B2.43B
Capital Expenditure
-926.40M-1.62B-551.90M-614.60M-429.60M
FREE CASH FLOW
3.67B3.40B6.53B2.00B2.00B

All data in USD

Charts